26 Sep 2012
DSM invests in Tsing Capital Environment Fund
Royal DSM, the global Life Sciences and Materials Sciences company, has invested in the 4th China Environment Fund of Tsing Capital in China. This is DSM's first venture capital fund investment in Asia. The China Environment Fund is a series of four funds, managed by Hong Kong based Tsing Capital. Financial details of the investment have not been disclosed.
Through its Venturing subsidiary, DSM has invested in strategic funds for the past 10 years. This investment in a cleantech fund in China is in line with DSM’s Strategy “DSM in motion, driving focused growth” with an increased focus on emerging economies.
Tsing Capital, founded in 2001, is an experienced VC fund focusing on cleantech in China. Backed by Tsinghua University, it has established broad industry networks and a strong brand name throughout the Asian VC markets. Tsing’s dealflow covers a range of activities in both the life sciences and materials sciences sectors, including sustainable agriculture, food processing, bio-based materials and renewable energy.
Pieter Wolters, Managing Director Venturing and Licensing at DSM explains: “By participating in this fund, DSM gains access to a significant dealflow for investments in life sciences and materials sciences in China. This will help us to build a solid base for DSM’s venturing activities in the greater China region. Moreover, Tsing’s core values and focus areas complement those of DSM. Virtually everything DSM currently undertakes is being driven by sustainability and our commitment to address the major global challenges and trends by successfully applying our bright science. This fits very well with Tsing’s credo ‘Doing Well by Doing Good’”.
“Over the past years, Tsing Capital has established an outstanding reputation, track record and credibility in China’s VC market” says Yu-Xiang (Leo) Liu, head of DSM’s venturing activities in Asia.
“The company’s performance track record is impressive. By participating in Tsing CEF IV, DSM has created an opportunity for an excellent strategic return in addition to the potentially attractive financial return that this fund offers.”
Reader enquiries
DSM Innovation Center
Mauritslaan 49
6129 EL Urmond
Netherlands
Notes for editors
Tsing Capital
Established in 2001, Tsing Capital is the pioneering and leading cleantech venture capital firm in China. Through its China Environment Fund and Yiyun Cleantech Fund series, Tsing Capital works intimately with its portfolio companies across China in areas of renewable energy, energy efficiency, environmental protection, new materials, sustainable transportation, smart grids, sustainable agriculture and cleaner production.
The China Environment Fund, established and managed by Tsing Capital since 2002, is the first series of funds in China with a focus in cleantech and environment related investments. As the pioneer and first mover in the pure play of environment venture capital investment in China, China Environment Fund has established a proven record of generating financial returns while achieving important environmental and social goals. China Environment Fund has a series of four funds. Investors include key development financial institutions, renowned family offices, major financial institutions and strategic multinational corporations/Fortune 500 companies.
More information can be found at www.tsingcapital.com.
DSM - Bright Science. Brighter Living.™
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.
Editorial enquiries
Leo Smit
DSM Innovation Center
Anouk Luykx
EMG